125 related articles for article (PubMed ID: 33494897)
1. Isolation, characterization and antibiotic resistance of Proteus mirabilis from Belgian broiler carcasses at retail and human stool.
Yu Z; Joossens M; Van den Abeele AM; Kerkhof PJ; Houf K
Food Microbiol; 2021 Jun; 96():103724. PubMed ID: 33494897
[TBL] [Abstract][Full Text] [Related]
2. Genotypic and phenotypic profiles of virulence factors and antimicrobial resistance of Proteus mirabilis isolated from chicken carcasses: potential zoonotic risk.
Sanches MS; Baptista AAS; de Souza M; Menck-Costa MF; Koga VL; Kobayashi RKT; Rocha SPD
Braz J Microbiol; 2019 Jul; 50(3):685-694. PubMed ID: 31049879
[TBL] [Abstract][Full Text] [Related]
3. Proteus mirabilis causing cellulitis in broiler chickens.
Sanches MS; Baptista AAS; de Souza M; Menck-Costa MF; Justino L; Nishio EK; Oba A; Bracarense APFRL; Rocha SPD
Braz J Microbiol; 2020 Sep; 51(3):1353-1362. PubMed ID: 32067208
[TBL] [Abstract][Full Text] [Related]
4. Survey of multidrug resistance integrative mobilizable elements SGI1 and PGI1 in Proteus mirabilis in humans and dogs in France, 2010-13.
Schultz E; Haenni M; Mereghetti L; Siebor E; Neuwirth C; Madec JY; Cloeckaert A; Doublet B
J Antimicrob Chemother; 2015 Sep; 70(9):2543-6. PubMed ID: 26066582
[TBL] [Abstract][Full Text] [Related]
5. Comparison of phenotypic and virulence genes characteristics in human and chicken isolates of Proteus mirabilis.
Barbour EK; Hajj ZG; Hamadeh S; Shaib HA; Farran MT; Araj G; Faroon O; Barbour KE; Jirjis F; Azhar E; Kumosani T; Harakeh S
Pathog Glob Health; 2012 Oct; 106(6):352-7. PubMed ID: 23182140
[TBL] [Abstract][Full Text] [Related]
6. Molecular Analysis, Biochemical Characterization, Antimicrobial Activity, and Immunological Analysis of Proteus mirabilis Isolated from Broilers.
Yeh HY; Line JE; Hinton A
J Food Sci; 2018 Mar; 83(3):770-779. PubMed ID: 29437227
[TBL] [Abstract][Full Text] [Related]
7. Extended-spectrum β-lactamase-producing Proteus mirabilis with multidrug resistance isolated from raw chicken in Singapore: Genotypic and phenotypic analysis.
Guo S; Aung KT; Tay MYF; Seow KLG; Ng LC; Schlundt J
J Glob Antimicrob Resist; 2019 Dec; 19():252-254. PubMed ID: 31639544
[TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics of Salmonella genomic island 1 in Proteus mirabilis isolates from poultry farms in China.
Lei CW; Zhang AY; Liu BH; Wang HN; Guan ZB; Xu CW; Xia QQ; Cheng H; Zhang DD
Antimicrob Agents Chemother; 2014 Dec; 58(12):7570-2. PubMed ID: 25267683
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and characterization of Salmonella infantis isolates originating from different points of the broiler chicken-human food chain in Hungary.
Nógrády N; Kardos G; Bistyák A; Turcsányi I; Mészáros J; Galántai Z; Juhász A; Samu P; Kaszanyitzky JE; Pászti J; Kiss I
Int J Food Microbiol; 2008 Sep; 127(1-2):162-7. PubMed ID: 18707787
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Susceptibility and Molecular Epidemiology of
Lin MF; Liou ML; Kuo CH; Lin YY; Chen JY; Kuo HY
Microb Drug Resist; 2019 Nov; 25(9):1338-1346. PubMed ID: 31295061
[TBL] [Abstract][Full Text] [Related]
11. Clonal relatedness of Proteus mirabilis strains causing urinary tract infections in companion animals and humans.
Marques C; Belas A; Aboim C; Trigueiro G; Cavaco-Silva P; Gama LT; Pomba C
Vet Microbiol; 2019 Jan; 228():77-82. PubMed ID: 30593384
[TBL] [Abstract][Full Text] [Related]
12. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
Khan AU; Musharraf A
Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of
Decôme M; Cuq B; Fairbrother JH; Gatel L; Conversy B
Can J Vet Res; 2020 Oct; 84(4):252-258. PubMed ID: 33012973
[TBL] [Abstract][Full Text] [Related]
14. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.
Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A
Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and molecular characterization of antimicrobial resistance in Proteus mirabilis isolates from dogs.
Harada K; Niina A; Shimizu T; Mukai Y; Kuwajima K; Miyamoto T; Kataoka Y
J Med Microbiol; 2014 Nov; 63(Pt 11):1561-1567. PubMed ID: 25187600
[TBL] [Abstract][Full Text] [Related]
16. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
[TBL] [Abstract][Full Text] [Related]
17. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
Saito R; Okugawa S; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K
Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340
[TBL] [Abstract][Full Text] [Related]
18. Increased mutability to fosfomycin resistance in Proteus mirabilis clinical isolates.
Fonseca MRB; Sato JL; Lima-Noronha MA; Migliorini LB; Fernández-Silva FS; Galhardo RS
Infect Genet Evol; 2018 Mar; 58():27-33. PubMed ID: 29248795
[TBL] [Abstract][Full Text] [Related]
19. Potential Probiotics Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 Co-Aggregate with Clinical Isolates of Proteus mirabilis and Prevent Biofilm Formation.
Algburi A; Alazzawi SA; Al-Ezzy AIA; Weeks R; Chistyakov V; Chikindas ML
Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1471-1483. PubMed ID: 31989448
[TBL] [Abstract][Full Text] [Related]
20. Proteus genomic island 1 (PGI1), a new resistance genomic island from two Proteus mirabilis French clinical isolates.
Siebor E; Neuwirth C
J Antimicrob Chemother; 2014 Dec; 69(12):3216-20. PubMed ID: 25114166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
